NCT00035594View on ClinicalTrials.gov

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

928

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

February 29, 2004

Study Completion Date

June 30, 2004

Conditions
Neutropenia
Interventions
DRUG

pegfilgrastim

Growth factor (GCSF) administered to promote neutrophil development post-chemotherapy.

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY